This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on October 27, 2022.
Return to the list of Patented Medicine Litigation page.
Lenalidomide
REVLIMID – Celgene (NOC Search)
Patents:
- 2476983: TARO PHARMACEUTICALS, REDDY, APOTEX,
- 2477301: , APOTEX, REDDY, TARO PHARMACEUTICALS
- 2537092: APOTEX, , TARO PHARMACEUTICALS, REDDY
- 2687924: TARO PHARMACEUTICALS, REDDY, APOTEX,
- 2687927: TARO PHARMACEUTICALS, REDDY, APOTEX,
- 2688694: REDDY, TARO PHARMACEUTICALS, , APOTEX
- 2688695: APOTEX, , TARO PHARMACEUTICALS, REDDY
- 2688708: APOTEX, , TARO PHARMACEUTICALS, REDDY
- 2688709: APOTEX, , TARO PHARMACEUTICALS, REDDY
- 2741412: REDDY, TARO PHARMACEUTICALS, , APOTEX
- 2741575: TARO PHARMACEUTICALS, REDDY, APOTEX,
Unknown/Other
- PM(NOC) – T-1527-18 (2019 FC 921) – T-1529-18 – T-1875-18 (2019 FC 1605)
APOTEX
REDDY
TARO PHARMACEUTICALS
- Infringement – T-1467-20
Return to the Patented Medicine Litigation page.